Biological Characteristics and Effect of Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) Grafting with Blood Plasma on Bone Regeneration in Rats

Cell Biochemistry and Biophysics

Volumn 63, Issue 2, 2012, Pages 171-181

  Qu, Zhiguo ^a   Guo, Libin ^a   Fang, Guojun ^a   Cui, Zhenghong ^a   Guo, Shengnan ^a   Liu, Ying ^a  

^a Siping Central Hospital   (China)

Author keywords

Bone regeneration; hUC MSCs; Plasma; Rat model; Stem cells

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; LEUKOCYTE ANTIGEN;

ANIMAL; ARTICLE; BONE REGENERATION; CALLUS; CELL CULTURE; CYTOLOGY; FRACTURE NONUNION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RADIOGRAPHY; RAT; SPRAGUE DAWLEY RAT; TIBIA; TIBIA FRACTURE; UMBILICAL CORD;

ANIMALS; ANTIGENS, CD; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONY CALLUS; CELLS, CULTURED; FRACTURES, MALUNITED; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TIBIAL FRACTURES; UMBILICAL CORD;

ANIMALIA; RATTUS;

EID: 84861231285     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9354-1     Document Type: Article

References (21)

1. Einhorn, T. A. (1995). Enhancement of fracture healing. Journal of Bone and Joint Surgery, 77, 940-956.
2. Coles, C. P., & Gross, M. (2000). Closed tibial shaft fractures: Management and treatment complications. A review of the prospective literature. Canadian Journal of Surgery, 43, 256-262.
3. Hadjiargyrou, M., Ahrens, W., & Rubin, C. T. (2000). Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. Journal of Bone and Mineral Research, 15, 1014-1023.
4. Younger, E. M., & Chapman, M. W. (1989). Morbidity at bone graft donor sites. Journal of Orthopaedic Trauma, 3, 192-195.
5. Grundel, R., Chapman, M., Yee, T., & Moore, D. C. (1991). Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clinical Orthopedics and Related Research, 266, 244-258.
6. Werntz, J., Lane, J., Burstein, A., Justin, R., Klein, R., & Tomin, E. (1996). Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. Journal of Orthopedic Research, 14, 85-93.
7. Muschler, G. F., Hiromori, N., Matsukura, Y., et al. (2003). Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clinical Orthopedics and Related Research, 407, 102-118.
8. Arinzeh, T. L., Peter, S. J., Archambault, M. P., et al. (2003). Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. Journal of Bone and Joint Surgery, 85-A, 1927-1935.
9. Bruder, S. P., Kurth, A. A., Shea, M., Hayes, W. C., Jaiswal, N., & Kadiyala, S. (1998). Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. Journal of Orthopedic Research, 16, 155-162.
10. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multi-lineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
11. Mitchell, K. E., Weiss, M. L., Mitchell, B. M., et al. (2003). Matrix cells from Wharton's jelly form neurons and glia. Stem Cells, 21, 50-60.
12. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M. M., & Davies, J. E. (2005). Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells, 23, 220-229.
13. Wang, H. S., Hung, S. C., Peng, S. T., et al. (2004). Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, 1330-1337.
14. Qu, Z. G., Mi, S. F., & Fang, G. J. (2009). Clinical study on treatment of bone nonunion with MSCs derived from human umbilical cord. Chinese Journal of Reparative and Reconstructive Surgery, 23(3), 345-347 (in Chinese).
15. Mariane, S., Yuri, B. M., Eder, Z., et al. (2009). Gene expression profile of mesenchymal stem cells from paired umbilical cord units: Cord is different from blood. Stem Cell Review, 5, 387-401.
16. Qu, Z. G., Liu, Y., Guo, L., et al. (2009). Percutaneous radiological autologous bone-marrow mesenchymal stem cells grafting integrating with blood plasma by injection in the part of thigh fracture: Seven-month follow-up effect evaluation in one case. Journal of Clinical Rehabilitative Tissue Engineering Research, 13, 7393-7396.
17. Wang, C. J., Iida, K., Egusa, H., Hokugo, A., Jewett, A., & Nishimura, I. (2008). Trabecular bone deterioration in col9a1 ± mice associated with enlarged osteoclasts adhered to collagen IX-deficient bone. Journal of Bone and Mineral Research, 23, 837-849.
18. Kratzel, C., Bergmann, C., Duda, G., Greiner, S., Schmidmaier, G., & Wildemann, B. (2008). Characterization of a rat osteotomy model with impaired healing. BMC Musculoskeletal Disorders, 9, 135.
19. Ren, H. Y., Zhao, Q. J., Xing, W., et al. (2010). Differentiation of human umbilical cord derived mesenchymal stem cells into low immunogenic and functional hepatocyte-like cells in vitro. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 32, 190-194.
20. Tipnis, S., Viswanathan, C., & Majumdar, A. S. (2010). Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunology and Cell Biology, 88, 795-806.
21. Chen, K., Wang, D., Du, W. T., et al. (2010). Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clinical Immunology, 135, 448-458.